secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2024-09-04T23:59:59+00:00
Accession:  0001388658-24-000156
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm licenses BioIntelliSense sensor tech for up to $35M + royalties; reaffirms FY2024 guidance
--------------------------------------------------------------------------------

- iRhythm pays $15M upfront and up to $20M in milestone payments for an exclusive ACM license of pulse oximetry, accelerometry, and non-invasive BP tech.
- Also purchased $40M in convertible notes from BioIntelliSense; $20M of Milestone Notes will be cancelled upon regulatory milestones.
- Low single-digit royalties on home sleep testing product sales; license expires 10 years after first commercial sale per country.
- iRhythm expects a non-recurring acquired IPR&D expense in 2024 but no material additional development costs; FY2024 revenue, gross margin, and adjusted EBITDA guidance reaffirmed.
- Deal aims to expand iRhythm's ACM platform and enable entry into sleep apnea and other adjacent indications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000156/0001388658-24-000156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000156/irtc-20240830.htm
  HTML page:      https://secwatch.observer/filing/0001388658-24-000156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer